- Home
- / LakeShore Biopharma
LakeShore Biopharma
Stock Price
$0.5
2024-07-26
Market Capitalization
$192.1 M
2024-07-26
Revenue
¥615 M
FY, 2025
LakeShore Biopharma Summary
Company Summary
- Overview
- LakeShore Biopharma (湖岸生物, formerly known as Yisheng Biopharma, YS Biopharma, 辽宁依生生物制药有限公司) is a company engaged in the development, production, marketing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. Its products include PIKA, an immunomodulating technology platform, and a series of preventive and therapeutic biologics.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Beijing, CN | view all locations
- Website
- https://en.lakeshorebio.com/
- Cybersecurity rating
Table of Contents
Key People
David (Hui) Shao, President and CEO
Brenda Wu, Chief Financial Officer
Zenaida Mojares, Chief Medical Officer
LocationsView all
2 locations detected
Beijing, Bei Jing Shi HQ
China
Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District
Gaithersburg, MD
United States
11 Firstfield Rd Suite A
LakeShore Biopharma Financials
Summary Financials
- Revenue (FY, 2025)
- ¥615.0M
- Gross profit (FY, 2025)
- ¥543.8M
- Net income (FY, 2025)
- (¥100.0M)
- Cash (FY, 2025)
- ¥28.1M
- EBIT (FY, 2025)
- (¥86.3M)
- Enterprise value
- $578.0M